Pharmashots interviews Laurent Levy about cancer-killing radiotherapy enhancers
Pharmashots - 10-Aug-2022NBTXR3 might give hope to patients who are ineligible for certain chemotheraphy
Join the club for FREE to access the whole archive and other member benefits.
Senior Editor at PharmaShots
Smriti is a Senior Editor at PharmaShots. She is curious and very passionate about recent updates and developments in the life sciences industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at smriti@pharmashots.com
Visit website: https://pharmashots.com/#smriti-bhardwaj
See alsoDetails last updated 15-Sep-2022
NBTXR3 might give hope to patients who are ineligible for certain chemotheraphy